메뉴 건너뛰기




Volumn 104, Issue 10, 2005, Pages 2189-2196

Race modifies the association between breast carcinoma pathologic prognostic idicators and the positive status for HER-2/neu

Author keywords

African American; Breast carcinoma; Caucasian; Ethnicity; HER 2 neu; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER RISK; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE;

EID: 27644465849     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21463     Document Type: Article
Times cited : (17)

References (34)
  • 1
    • 37049183697 scopus 로고
    • Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
    • Salmon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177-182.
    • (1987) Science , vol.235 , pp. 177-182
    • Salmon, D.J.1    Clark, G.M.2    Wong, S.G.3
  • 2
    • 0031954313 scopus 로고    scopus 로고
    • Neu/ErB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
    • Toronto Breast Cancer Study Group
    • Andrulis IL, Bull SB, Blackstein ME, et al. Neu/ErB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol. 1998;16:1340-1349.
    • (1998) J Clin Oncol , vol.16 , pp. 1340-1349
    • Andrulis, I.L.1    Bull, S.B.2    Blackstein, M.E.3
  • 3
    • 10344230552 scopus 로고    scopus 로고
    • Prognostic significance of HER-2/neu positive breast carcinoma as a particular subset with peculiar clinical behavior
    • Tetu B, Brisson J. Prognostic significance of HER-2/neu positive breast carcinoma as a particular subset with peculiar clinical behavior. Clin Cancer Res. 2002;8:520-525.
    • (2002) Clin Cancer Res , vol.8 , pp. 520-525
    • Tetu, B.1    Brisson, J.2
  • 4
    • 0029662337 scopus 로고    scopus 로고
    • c-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early stage breast cancer without axillary lymph node metastases
    • Carlomagno C, Perrone F, Gallo C, et al. c-erbB-2 overexpression decreases the benefit of adjuvant tamoxifen in early stage breast cancer without axillary lymph node metastases. J Clin Oncol. 1996;14:2702-2708.
    • (1996) J Clin Oncol , vol.14 , pp. 2702-2708
    • Carlomagno, C.1    Perrone, F.2    Gallo, C.3
  • 5
    • 0034896257 scopus 로고    scopus 로고
    • Chemotherapy response of breast cancer depends on Her-2 status and anthracycline dose intensity in the neoadjuvant setting
    • Petit T, Borel C, Ghnassia JP, et al. Chemotherapy response of breast cancer depends on Her-2 status and anthracycline dose intensity in the neoadjuvant setting. Clin Cancer Res. 2001;7:1577-1581.
    • (2001) Clin Cancer Res , vol.7 , pp. 1577-1581
    • Petit, T.1    Borel, C.2    Ghnassia, J.P.3
  • 6
    • 0034780374 scopus 로고    scopus 로고
    • Significance of, and optimal screening for, Her-2 gene amplification and protein overexpression in breast carcinoma
    • Funkhouser WK, Kaiser-Rogers K. Significance of, and optimal screening for, Her-2 gene amplification and protein overexpression in breast carcinoma [Review]. Ann Clin Lab Sci. 2001;31:349-357.
    • (2001) Ann Clin Lab Sci , vol.31 , pp. 349-357
    • Funkhouser, W.K.1    Kaiser-Rogers, K.2
  • 7
    • 0032875086 scopus 로고    scopus 로고
    • Evaluation of the HER-2/neu (erbB-2) status in breast cancer: From bench to bedside
    • Hanna W, Kahn HGJ, Trudeau M. Evaluation of the HER-2/neu (erbB-2) status in breast cancer: from bench to bedside. Med Pathol. 1999;12:827-834.
    • (1999) Med Pathol , vol.12 , pp. 827-834
    • Hanna, W.1    Kahn, H.G.J.2    Trudeau, M.3
  • 8
    • 0031010751 scopus 로고    scopus 로고
    • Prognosis among African-American women and white women with lymph node negative breast carcinoma. Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
    • Dignam JJ, Redmond CK, Fisher B, et al. Prognosis among African-American women and white women with lymph node negative breast carcinoma. Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Cancer. 1997;80:80-90.
    • (1997) Cancer , vol.80 , pp. 80-90
    • Dignam, J.J.1    Redmond, C.K.2    Fisher, B.3
  • 9
    • 0033984903 scopus 로고    scopus 로고
    • Differences in breast cancer prognosis among African-American and Caucasian women
    • Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA-Cancer J Clin. 2000;50:50-64.
    • (2000) CA-Cancer J Clin , vol.50 , pp. 50-64
    • Dignam, J.J.1
  • 10
    • 0037215974 scopus 로고    scopus 로고
    • Overview of the summit meeting evaluating research in African-American women
    • Jones LA, Brawley O, Johnson-Thompson M, et al. Overview of the summit meeting evaluating research in African-American women. Cancer. 2003;97:207-210.
    • (2003) Cancer , vol.97 , pp. 207-210
    • Jones, L.A.1    Brawley, O.2    Johnson-Thompson, M.3
  • 11
    • 0036604262 scopus 로고    scopus 로고
    • African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast
    • Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival. A meta-analysis of 14 studies involving over 10,000 African-American and 40,000 white American patients with carcinoma of the breast. Cancer. 2002;94:2844-2854.
    • (2002) Cancer , vol.94 , pp. 2844-2854
    • Newman, L.A.1    Mason, J.2    Cote, D.3
  • 12
    • 0033983963 scopus 로고    scopus 로고
    • Racial differences in breast carcinoma survival
    • Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer. 2000;88:114-123.
    • (2000) Cancer , vol.88 , pp. 114-123
    • Joslyn, S.A.1    West, M.M.2
  • 13
    • 0035985483 scopus 로고    scopus 로고
    • Hormone receptors in breast cancer: Racial differences in distribution and survival
    • Joslyn SA. Hormone receptors in breast cancer: racial differences in distribution and survival. Breast Cancer Res Treat. 2002;73:45-59.
    • (2002) Breast Cancer Res Treat , vol.73 , pp. 45-59
    • Joslyn, S.A.1
  • 14
    • 0029866754 scopus 로고    scopus 로고
    • Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic women. An analysis of 13,239 cases
    • Gapstur SM, Dupuis J, Gann P, et al. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic women. An analysis of 13,239 cases. Cancer. 1996;77: 1465-1471.
    • (1996) Cancer , vol.77 , pp. 1465-1471
    • Gapstur, S.M.1    Dupuis, J.2    Gann, P.3
  • 15
    • 0023100401 scopus 로고
    • A comparison of estrogen and progesterone receptors in black and white breast cancer patients
    • Beverly LN, Flanders WD, GO RCP, et al. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health. 1987;77:351-353.
    • (1987) Am J Public Health , vol.77 , pp. 351-353
    • Beverly, L.N.1    Flanders, W.D.2    Go, R.C.P.3
  • 16
    • 0037108283 scopus 로고    scopus 로고
    • Racial differences in treatment and survival from early stage breast carcinoma
    • Joslyn SA. Racial differences in treatment and survival from early stage breast carcinoma. Cancer. 2002;95:1759-1766.
    • (2002) Cancer , vol.95 , pp. 1759-1766
    • Joslyn, S.A.1
  • 17
    • 0023841565 scopus 로고
    • The prognostic value and relationships of patient characteristics, estrogen and progesterone receptors, and site of relapse in primary breast cancer
    • Alexieva-Figusch J, Van Putten WI, Blankenstein MA, et al. The prognostic value and relationships of patient characteristics, estrogen and progesterone receptors, and site of relapse in primary breast cancer. Cancer. 1988;61:758-768.
    • (1988) Cancer , vol.61 , pp. 758-768
    • Alexieva-Figusch, J.1    Van Putten, W.I.2    Blankenstein, M.A.3
  • 18
    • 0036645259 scopus 로고    scopus 로고
    • Ethnicity related differences in the survival of young breast carcinoma patients
    • Newman LA, Bunner S, Carolin K, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer. 2002;95:21-27.
    • (2002) Cancer , vol.95 , pp. 21-27
    • Newman, L.A.1    Bunner, S.2    Carolin, K.3
  • 19
    • 0029039188 scopus 로고
    • Ethnic differences in risk and prognostic factors for breast cancer
    • Weiss SE, Tamer PI, Ahmed S, et al. Ethnic differences in risk and prognostic factors for breast cancer. Cancer. 1995; 76:268-274.
    • (1995) Cancer , vol.76 , pp. 268-274
    • Weiss, S.E.1    Tamer, P.I.2    Ahmed, S.3
  • 20
    • 0028217282 scopus 로고
    • Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States
    • Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
    • (1994) J Natl Cancer Inst , vol.86 , pp. 705-712
    • Elledge, R.M.1    Clark, G.M.2    Chamness, G.C.3
  • 22
    • 0033142114 scopus 로고    scopus 로고
    • Prognostic value of plasma HER-2/new in African-American and Hispanic women with breast cancer
    • Wu Y, Khan H, Chillar R, et al. Prognostic value of plasma HER-2/new in African-American and Hispanic women with breast cancer. Int J Oncol. 1999;14:1021-1037.
    • (1999) Int J Oncol , vol.14 , pp. 1021-1037
    • Wu, Y.1    Khan, H.2    Chillar, R.3
  • 23
    • 0037440261 scopus 로고    scopus 로고
    • Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
    • Konecny G, Pauletti G, Pegram M, et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst. 2003;95:142-153.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 142-153
    • Konecny, G.1    Pauletti, G.2    Pegram, M.3
  • 24
    • 0345098483 scopus 로고    scopus 로고
    • Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    • Taucher S, Rudas M, Mader RM, et al. Do we need HER-2/ neu testing for all patients with primary breast carcinoma? Cancer. 2003;98:2547-2453.
    • (2003) Cancer , vol.98 , pp. 2547-12453
    • Taucher, S.1    Rudas, M.2    Mader, R.M.3
  • 25
    • 0032055144 scopus 로고    scopus 로고
    • Breast carcinoma survival analysis for African-American and white women in an equal-access healthcare system
    • Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African-American and white women in an equal-access healthcare system. Cancer. 1998;82:1310-1318.
    • (1998) Cancer , vol.82 , pp. 1310-1318
    • Wojcik, B.E.1    Spinks, M.K.2    Optenberg, S.A.3
  • 26
    • 0041887167 scopus 로고    scopus 로고
    • Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense healthcare system
    • Jatoi I, Becher H, Leake CR. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense healthcare system. Cancer. 2003;98:894-899.
    • (2003) Cancer , vol.98 , pp. 894-899
    • Jatoi, I.1    Becher, H.2    Leake, C.R.3
  • 27
    • 0041736242 scopus 로고    scopus 로고
    • Racial/ethnic disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy
    • Griggs JJ, Sorbero ME, Stark A, et al. Racial/ethnic disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003;81:21-31.
    • (2003) Breast Cancer Res Treat , vol.81 , pp. 21-31
    • Griggs, J.J.1    Sorbero, M.E.2    Stark, A.3
  • 28
    • 2642575788 scopus 로고    scopus 로고
    • Racial differences in the expression of cell cycle regulator proteins in breast carcinoma. Study of young African-American and white women in Atlanta, Georgia
    • Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle regulator proteins in breast carcinoma. Study of young African-American and white women in Atlanta, Georgia. Cancer. 2004;100:2533-2542.
    • (2004) Cancer , vol.100 , pp. 2533-2542
    • Porter, P.L.1    Lund, M.J.2    Lin, M.G.3
  • 29
    • 4444286069 scopus 로고    scopus 로고
    • African American/white differences in breast carcinoma. P53 alterations and other tumor characteristics
    • Jones BA, Kasi SV, Howe CL, et al. African American/white differences in breast carcinoma. P53 alterations and other tumor characteristics. Cancer. 2004;101:1293-1301.
    • (2004) Cancer , vol.101 , pp. 1293-1301
    • Jones, B.A.1    Kasi, S.V.2    Howe, C.L.3
  • 30
    • 0036468764 scopus 로고    scopus 로고
    • Functionally active estrogen receptor isoform profiles in the breast tumors of African-American women are different from the profiles in breast tumors of Caucasian women
    • Poola I, Clarke R, DeWitty R, et al. Functionally active estrogen receptor isoform profiles in the breast tumors of African-American women are different from the profiles in breast tumors of Caucasian women. Cancer. 2002;94:615-623.
    • (2002) Cancer , vol.94 , pp. 615-623
    • Poola, I.1    Clarke, R.2    DeWitty, R.3
  • 31
    • 0037012341 scopus 로고    scopus 로고
    • Disaggregating the effects of race and poverty on breast cancer outcomes
    • Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94:471-473.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 471-473
    • Brawley, O.W.1
  • 32
    • 0028842829 scopus 로고
    • Association of education and income with estrogen receptor status in primary breast cancer
    • Gordon NH. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemol. 1995;142:796-803.
    • (1995) Am J Epidemol , vol.142 , pp. 796-803
    • Gordon, N.H.1
  • 33
    • 2642573558 scopus 로고    scopus 로고
    • Participation in cancer clinical trials. Race-, sex- and age-based disparities
    • Murthy VH, Krumholz HM, Gross GP. Participation in cancer clinical trials. Race-, sex- and age-based disparities. JAMA. 2004;291:2720-2726.
    • (2004) JAMA , vol.291 , pp. 2720-2726
    • Murthy, V.H.1    Krumholz, H.M.2    Gross, G.P.3
  • 34
    • 27644572328 scopus 로고    scopus 로고
    • National Institutes of Health. http://www4.od.nih.gov/ orwh/revitalization.pdf [accessed Nov 15, 2004].


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.